BRIEF published on 04/04/2024 at 15:05, 2 years 3 months ago First Phase 2 Clinical Trial of Lassa Fever Vaccine Begins in Nigeria Phase 2 Clinical Trial Global Health Lassa Fever Vaccine IAVI CEPI
PRESS RELEASE published on 04/04/2024 at 15:00, 2 years 3 months ago Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored by IAVI CEPI-funded study in Nigeria evaluates safety, tolerability, and immunogenicity of IAVI's Lassa fever vaccine candidate. First Phase 2 trial for any Lassa vaccine Phase 2 Trial IAVI CEPI Lassa Fever Vaccine Candidate
PRESS RELEASE published on 12/18/2023 at 15:00, 2 years 6 months ago IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa
PRESS RELEASE published on 07/07/2023 at 15:00, 3 years ago Germany Issues Award to IAVI to Support Development of the MTBVAC Tuberculosis Vaccine Candidate
PRESS RELEASE published on 06/27/2023 at 15:00, 3 years ago IAVI Starts First-in-Human Phase I Clinical Trial of Single-Dose Sudan Virus Vaccine Candidate
PRESS RELEASE published on 05/17/2023 at 15:00, 3 years 1 month ago Zendal and IAVI Announce Expanded Agreement to Partner on Development of TB Vaccine Candidate MTBVAC
PRESS RELEASE published on 03/02/2023 at 15:00, 3 years 4 months ago IAVI and BARDA Expand Partnership to Advance IAVI's Filovirus Vaccine Candidates
Published on 07/14/2026 at 01:45, 1 hour 35 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 3 hours 19 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 4 hours 10 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 5 hours 45 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 7 hours 20 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/13/2026 at 22:30, 4 hours 50 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 5 hours 59 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 6 hours 2 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 6 hours 32 minutes ago EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 6 hours 57 minutes ago EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
Published on 07/13/2026 at 18:00, 9 hours 20 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 9 hours 20 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 9 hours 20 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
